369 related articles for article (PubMed ID: 17071602)
1. Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma.
Chiosea S; Jelezcova E; Chandran U; Acquafondata M; McHale T; Sobol RW; Dhir R
Am J Pathol; 2006 Nov; 169(5):1812-20. PubMed ID: 17071602
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Dicer in precursor lesions of lung adenocarcinoma.
Chiosea S; Jelezcova E; Chandran U; Luo J; Mantha G; Sobol RW; Dacic S
Cancer Res; 2007 Mar; 67(5):2345-50. PubMed ID: 17332367
[TBL] [Abstract][Full Text] [Related]
3. Stimuli-dependent cleavage of Dicer during apoptosis.
Matskevich AA; Moelling K
Biochem J; 2008 Jun; 412(3):527-34. PubMed ID: 18289125
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of dicer expression in ovarian cancer tissues.
Pampalakis G; Diamandis EP; Katsaros D; Sotiropoulou G
Clin Biochem; 2010 Feb; 43(3):324-7. PubMed ID: 19782670
[TBL] [Abstract][Full Text] [Related]
5. Expression and role of Foxa proteins in prostate cancer.
Mirosevich J; Gao N; Gupta A; Shappell SB; Jove R; Matusik RJ
Prostate; 2006 Jul; 66(10):1013-28. PubMed ID: 16001449
[TBL] [Abstract][Full Text] [Related]
6. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Dicer predicts poor survival in colorectal cancer.
Faber C; Horst D; Hlubek F; Kirchner T
Eur J Cancer; 2011 Jun; 47(9):1414-9. PubMed ID: 21345667
[TBL] [Abstract][Full Text] [Related]
8. The significance of LMO2 expression in the progression of prostate cancer.
Ma S; Guan XY; Beh PS; Wong KY; Chan YP; Yuen HF; Vielkind J; Chan KW
J Pathol; 2007 Feb; 211(3):278-85. PubMed ID: 17167821
[TBL] [Abstract][Full Text] [Related]
9. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications.
Chen G; Shukeir N; Potti A; Sircar K; Aprikian A; Goltzman D; Rabbani SA
Cancer; 2004 Sep; 101(6):1345-56. PubMed ID: 15316903
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma.
Fixemer T; Remberger K; Bonkhoff H
Prostate; 2003 Feb; 54(2):79-87. PubMed ID: 12497580
[TBL] [Abstract][Full Text] [Related]
12. Expression levels of the microRNA processing enzymes Drosha and dicer in epithelial skin cancer.
Sand M; Gambichler T; Skrygan M; Sand D; Scola N; Altmeyer P; Bechara FG
Cancer Invest; 2010 Jul; 28(6):649-53. PubMed ID: 20210522
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expression.
Faggad A; Budczies J; Tchernitsa O; Darb-Esfahani S; Sehouli J; Müller BM; Wirtz R; Chekerov R; Weichert W; Sinn B; Mucha C; Elwali NE; Schäfer R; Dietel M; Denkert C
J Pathol; 2010 Feb; 220(3):382-91. PubMed ID: 19960504
[TBL] [Abstract][Full Text] [Related]
14. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA
Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446
[TBL] [Abstract][Full Text] [Related]
15. Dicer and outcomes in patients with acute myeloid leukemia (AML).
Martin MG; Payton JE; Link DC
Leuk Res; 2009 Aug; 33(8):e127. PubMed ID: 19278725
[No Abstract] [Full Text] [Related]
16. c-met proto-oncogene expression in benign and malignant human prostate tissues.
Pisters LL; Troncoso P; Zhau HE; Li W; von Eschenbach AC; Chung LW
J Urol; 1995 Jul; 154(1):293-8. PubMed ID: 7539865
[TBL] [Abstract][Full Text] [Related]
17. Single processing center models for human Dicer and bacterial RNase III.
Zhang H; Kolb FA; Jaskiewicz L; Westhof E; Filipowicz W
Cell; 2004 Jul; 118(1):57-68. PubMed ID: 15242644
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of cathepsin X in prostate cancer and prostatic intraepithelial neoplasia.
Nägler DK; Krüger S; Kellner A; Ziomek E; Menard R; Buhtz P; Krams M; Roessner A; Kellner U
Prostate; 2004 Jul; 60(2):109-19. PubMed ID: 15162377
[TBL] [Abstract][Full Text] [Related]
19. Glutathione S-transferase: differential expression of alpha, mu, and pi isoenzymes in benign prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma.
Bostwick DG; Meiers I; Shanks JH
Hum Pathol; 2007 Sep; 38(9):1394-401. PubMed ID: 17555796
[TBL] [Abstract][Full Text] [Related]
20. Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer.
Hermani A; Hess J; De Servi B; Medunjanin S; Grobholz R; Trojan L; Angel P; Mayer D
Clin Cancer Res; 2005 Jul; 11(14):5146-52. PubMed ID: 16033829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
